共 50 条
Diabetes mellitus: what the neurologists need to know
被引:2
作者:
Stephens, Jeffrey Wayne
[1
]
Williams, David M.
[2
]
Chudleigh, Richard
[3
]
机构:
[1] Swansea Univ Med Sch, Diabetes Res Grp, Swansea, W Glam, Wales
[2] Morriston Hosp, Diabetes Ctr, Swansea, W Glam, Wales
[3] Singleton Hosp, Diabetes Ctr, Swansea, W Glam, Wales
关键词:
diabetes mellitus;
BETA-CELL;
TYPE-2;
COMPLICATIONS;
ASSOCIATION;
DYSFUNCTION;
MANAGEMENT;
RISK;
ROSIGLITAZONE;
HYPERGLYCEMIA;
PREVALENCE;
D O I:
10.1136/pn-2022-003395
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Diabetes mellitus is a common condition associated with numerous complications and comorbidities. The diabetes spectrum includes type 1, type 2 and other forms of diabetes, which may be associated with medical therapies and genetic factors. Type 2 diabetes is managed with lifestyle, oral therapies, non-insulin-based injectables and subsequently insulin. Type 1 diabetes requires insulin from the time of diagnosis. In recent years, there have been considerable developments in the therapies available to treat type 2 diabetes and some of these also afford cardiorenal protection. This review summarises the nature, complications and therapeutic advances in the field of diabetes and provides a concise review for neurologists. Managing diabetes optimally prevents complications and all medical specialties need a basic understanding of the principles involved in diabetes care.
引用
收藏
页码:532 / 539
页数:9
相关论文
共 50 条